149 related articles for article (PubMed ID: 34613453)
1. Characteristics of clinical relapses and patient-oriented long-term outcomes of patients with anti-N-methyl-D-aspartate receptor encephalitis.
Hirose S; Hara M; Kamei S; Dalmau J; Nakajima H
J Neurol; 2022 May; 269(5):2486-2492. PubMed ID: 34613453
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and long-term prognosis of relapsing anti-N-methyl-D-aspartate receptor encephalitis: a retrospective, multicenter, self-controlled study.
Zeng W; Cao L; Zheng J; Yu L
Neurol Sci; 2021 Jan; 42(1):199-207. PubMed ID: 32601745
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing prognosis and relapse in patients with anti-N-methyl-D-aspartate receptor encephalitis.
Wu Q; Xie Q; Liu L; Meng C; Wang J
Mult Scler Relat Disord; 2023 Jun; 74():104697. PubMed ID: 37031550
[TBL] [Abstract][Full Text] [Related]
4. [Immunotherapy strategy for 35 cases of severe anti-N-methyl-D-aspartate receptor encephalitis].
Yuan J; Peng B; Guan HZ; Huang Y; Lu Q; Ren HT; Yang XZ; Jiang N; Zhu YC; Cui LY
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(13):1035-9. PubMed ID: 27055797
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of clinical characteristics and outcomes of mechanically ventilated patients with anti-N-methyl-D-aspartate receptor encephalitis].
Zhang Y; Su YY; Gao DQ; Ye H
Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(3):187-192. PubMed ID: 28162168
[No Abstract] [Full Text] [Related]
6. Surgical outcomes in patients with anti-N-methyl D-aspartate receptor encephalitis with ovarian teratoma.
Dai Y; Zhang J; Ren H; Zhou X; Chen J; Cui L; Lang J; Guan H; Sun D
Am J Obstet Gynecol; 2019 Nov; 221(5):485.e1-485.e10. PubMed ID: 31128109
[TBL] [Abstract][Full Text] [Related]
7. [Cryptococcal Encephalitis Complicating Anti-N-methyl-D-aspartate Receptor Encephalitis in an Immunosuppressed Patient].
Liu D; Xu H; Yi F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Jun; 42(3):417-420. PubMed ID: 32616142
[TBL] [Abstract][Full Text] [Related]
8. Long-term Functional Outcomes and Relapse of Anti-NMDA Receptor Encephalitis: A Cohort Study in Western China.
Gong X; Chen C; Liu X; Lin J; Li A; Guo K; Zhou D; Hong Z
Neurol Neuroimmunol Neuroinflamm; 2021 Mar; 8(2):. PubMed ID: 33589542
[TBL] [Abstract][Full Text] [Related]
9. NMDA-receptor encephalitis in Denmark from 2009 to 2019: a national cohort study.
Nissen MS; Ørvik MS; Nilsson AC; Ryding M; Lydolph M; Blaabjerg M
J Neurol; 2022 Mar; 269(3):1618-1630. PubMed ID: 34351472
[TBL] [Abstract][Full Text] [Related]
10. Frequency and characteristics of isolated psychiatric episodes in anti–N-methyl-d-aspartate receptor encephalitis.
Kayser MS; Titulaer MJ; Gresa-Arribas N; Dalmau J
JAMA Neurol; 2013 Sep; 70(9):1133-9. PubMed ID: 23877059
[TBL] [Abstract][Full Text] [Related]
11. The prognosis of late-onset anti-N-methyl-D-aspartate receptor encephalitis in China.
Sun Y; Ren G; Ren J; Shan W; Han X; Lian Y; Wang T; Wang Q
Acta Neurol Scand; 2022 Apr; 145(4):449-455. PubMed ID: 34918336
[TBL] [Abstract][Full Text] [Related]
12. Novel qEEG Biomarker to Distinguish Anti-NMDAR Encephalitis From Other Types of Autoimmune Encephalitis.
Mizoguchi T; Hara M; Hirose S; Nakajima H
Front Immunol; 2022; 13():845272. PubMed ID: 35242143
[TBL] [Abstract][Full Text] [Related]
13. Assessment of long-term psychosocial outcomes in anti-NMDA receptor encephalitis.
Blum RA; Tomlinson AR; Jetté N; Kwon CS; Easton A; Yeshokumar AK
Epilepsy Behav; 2020 Jul; 108():107088. PubMed ID: 32375094
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis of relapsing anti-N-methyl-D-aspartate receptor encephalitis].
Hongzhi G; Weize K; Bin P; Yan H; Qiang L; Yuan J; Qing L; Hang S; Haitao R; Yicheng Z; Dawei S; Liying C
Zhonghua Yi Xue Za Zhi; 2015 Apr; 95(13):996-1001. PubMed ID: 26506710
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of 71 cases of anti-N-methyl-D-aspartate receptor encephalitis in children].
Wang GL; Yin F; Wang Y; Zhang WX; He F; Yang LF; Wu LW; Peng J
Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):125-130. PubMed ID: 30695887
[No Abstract] [Full Text] [Related]
16. Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis.
Nosadini M; Eyre M; Molteni E; Thomas T; Irani SR; Dalmau J; Dale RC; Lim M; ; Anlar B; Armangue T; Benseler S; Cellucci T; Deiva K; Gallentine W; Gombolay G; Gorman MP; Hacohen Y; Jiang Y; Lim BC; Muscal E; Ndondo A; Neuteboom R; Rostásy K; Sakuma H; Sartori S; Sharma S; Tenembaum SN; Van Mater HA; Wells E; Wickstrom R; Yeshokumar AK
JAMA Neurol; 2021 Nov; 78(11):1333-1344. PubMed ID: 34542573
[TBL] [Abstract][Full Text] [Related]
17. Relapse factors of patients of anti-N-methyl-D-aspartate receptor encephalitis.
Zhao YY; Wang HX; Wang M; Yuan B; Sun TW; Xu YM
Acta Neurol Scand; 2022 Apr; 145(4):434-441. PubMed ID: 34927233
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of anti-
Hirose S; Hara M; Yokota Y; Nakajima H
Front Neurol; 2023; 14():1170961. PubMed ID: 37273709
[TBL] [Abstract][Full Text] [Related]
19. Association between clinical factors and orofacial dyskinesias in anti-N-methyl-D-aspartate receptor encephalitis.
Hang H; Lin L; Li D; Li J; Shi J; Lu J
Brain Behav; 2022 Jul; 12(7):e2638. PubMed ID: 35620876
[TBL] [Abstract][Full Text] [Related]
20. Anti-N-Methyl-D-Aspartate Receptor Encephalitis in Children and Adolescents.
Scheer S; John RM
J Pediatr Health Care; 2016; 30(4):347-58. PubMed ID: 26507948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
